Identification of treatment-resistant major depressive disorder using a machine learning algorithm

被引：0
|
作者：
Semeniuta, Daniel [1 ]
Marci, Carl [1 ]
Bandaria, Jigar [1 ]
Zabinski, Joseph W. [1 ]
Paulus, Jessica K. [1 ]
Orsini, Lucinda [2 ]
Boussios, Costas [1 ]
机构：
[1] OM1 Inc, Boston, MA USA
[2] Compass Pathways Ltd, London, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
956
引用
收藏
页码：447 / 447
页数：1
相关论文
共 50 条
  • [31] Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
    G I Papakostas
    D F Ionescu
    Molecular Psychiatry, 2015, 20 : 1142 - 1150
  • [32] The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
    Kwasna, Julia
    Cubala, Wieslaw Jerzy
    Kwasny, Aleksander
    Wilkowska, Alina
    PHARMACOLOGICAL REPORTS, 2024, 76 (06) : 1318 - 1324
  • [33] Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder
    Ivanova, Jasmina I.
    Birnbaum, Howard G.
    Kidolezi, Yohanne
    Subramanian, Ganesh
    Khan, Sajjad A.
    Stensland, Michael D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2475 - 2484
  • [34] Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder
    Yamasaki, Katsuhiko
    Hasegawa, Tomonori
    Takeda, Masatoshi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 130 - 137
  • [35] Sertoli cell therapy: A novel possible treatment strategy for treatment-resistant major depressive disorder
    Loftis, J. M.
    MEDICAL HYPOTHESES, 2011, 77 (01) : 35 - 42
  • [36] An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression
    Wu, Bingcao
    Cai, Qian
    Sheehan, John J.
    Benson, Carmela
    Connolly, Nancy
    Alphs, Larry
    PLOS ONE, 2019, 14 (08):
  • [37] MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    Dunlop, Katharine
    Gaprielian, Pauline
    Blumberger, Daniel
    Daskalakis, Zafiris J.
    Kennedy, Sidney H.
    Giacobbe, Peter
    Downar, Jonathan
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (102):
  • [38] Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders
    Rech, Peterson
    Custodio, Rodrigo Miranda
    Uggioni, Maria Laura Rodrigues
    Prestes, Gabriele Silveira
    Marcal, Fernanda
    Silveira, Vitoria Pedroso
    Dagostin, Valdemira Santina
    Colonetti, Tamy
    Rosa, Maria Ines
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 129
  • [39] Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder
    Shah, Drishti
    Zheng, Wanhong
    Allen, Lindsay
    Wei, Wenhui
    LeMasters, Traci
    Madhavan, Suresh
    Sambamoorthi, Usha
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (05) : 847 - 859
  • [40] Using machine-learning to predict sudden gains in treatment for major depressive disorder
    Aderka, Idan M.
    Kauffmann, Amitay
    Shalom, Jonathan G.
    Beard, Courtney
    Bjorgvinsson, Throstur
    BEHAVIOUR RESEARCH AND THERAPY, 2021, 144
12345